Teen with Rare Condition Hopes to Stop Growing | Sainte-Justine Hospital
MONTREAL – A patient at CHU Sainte-Justine, a Montreal children’s hospital, is hoping a recent medical breakthrough will allow him to stop growing, according to a report in Le Journal de Montréal. The patient, whose name has not been released, suffers from chronic granulomatous disease (CGD), a rare genetic disorder affecting the immune system.
The hospital announced earlier this month what it calls a possible “cure” for CGD, achieved through gene therapy. The treatment involves modifying the patient’s own blood stem cells to correct the genetic defect causing the disease. CityNews Montreal reported the treatment is the first of its kind globally.
CGD leaves patients vulnerable to life-threatening infections due to their immune cells’ inability to fight off bacteria and fungi. The disease often manifests in early childhood, and can lead to a range of complications, including frequent infections, inflammation, and the formation of granulomas – small areas of immune cell accumulation.
The patient quoted in Le Journal de Montréal expressed a simple desire: “On touche du bois pour que ça arrête” – “We’re keeping our fingers crossed that it stops.” This refers to the uncontrolled growth that can be a symptom of the disease and its treatment. The gene therapy aims to not only correct the immune deficiency but also to halt the progression of the disease and its associated complications.
While the hospital is cautiously optimistic, officials emphasize that it is still early days. Long-term monitoring will be crucial to assess the durability of the treatment and to identify any potential side effects. The success of this initial case could pave the way for similar treatments for other children with CGD worldwide.
The development comes as healthcare professionals are increasingly focused on non-pharmacological methods for managing pain in pediatric procedures. A recent study highlighted in Nature explores training healthcare professionals in hypnosis-derived communication techniques to mitigate procedural pain in children. This research, while separate from the CGD breakthrough, underscores a broader trend toward innovative approaches to pediatric care.
Elsewhere, Sectra, a medical imaging company, recently secured a $353 million enterprise imaging contract, according to Radiology Business, demonstrating continued investment in advanced medical technologies. This contract was awarded despite ongoing legal challenges, highlighting the demand for sophisticated imaging solutions in modern healthcare.
Researchers are also investigating the impact of Human Papillomavirus (HPV) viral load during pregnancy and its connection to vertical transmission, as reported by Wiley Online Library. This research focuses on a different area of pediatric health, but illustrates the ongoing efforts to understand and address health challenges affecting children and mothers.